跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 30,716 条关于
“recombinant-protein vaccines”
全部
30,716
临床试验
16,028
药物
6,861
机构
147
资讯
7,680
7个月前
CEPI Partners with Samsung Biologics to Strengthen Global Vaccine Manufacturing for Future Pandemics
2个月前
Vaccine Adjuvants Market Projected to Reach USD 6.19 Billion by 2035, Driven by mRNA and Oncology Vaccine Innovation
2年前
Novavax Advances Global Vaccine Development with Protein-Based Platform and Matrix-M Technology
去年
South Korea Approves World's First Recombinant Anthrax Vaccine BARYTHRAX
2年前
DxVx Advances Licensing Deal for OVM-200 Cancer Vaccine in Asian Markets
9个月前
Multi-Component Intranasal COVID-19 Vaccine Shows Promise in Preclinical and Early Human Studies
2个月前
Dyadic Secures Japanese Patent for C1 Recombinant Protein Platform, Accelerates Asia-Pacific Expansion
上个月
Biopharmaceutical PAT Market Projected to Reach $4.32 Billion by 2031, Driven by Vaccine Manufacturing and Asia Pacific Expansion
9个月前
Dyadic Applied BioSolutions Expands Strategic Partnerships to Accelerate Commercial Growth of Recombinant Protein Portfolio
上个月
Research Use Recombinant Protein Market Projected to Reach $1.55 Billion by 2031, Driven by Expanding Drug Discovery Pipelines
第 1 页，共 768 页
上一页
下一页
